Synaptic Transmission: Inhibition of Neurotransmitter Release by Botulinum Toxins-Reference-Cited by-同舟云学术

Synaptic Transmission: Inhibition of Neurotransmitter Release by Botulinum Toxins

Published:2003-07 Issue:s1 Volume:43 Page:16-24
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache

Author:

Dolly Oliver

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1526-4610.43.7s.4.x/fullpdf

Reference14 articles.

1. 1. Dolly JO. Biochemistry of acetylcholine receptors from skeletal muscle. In: Tipton KF, ed. Int Rev Biochem (Physiol Pharmacol Biochem.) Baltimore, Md: University Park Press; 1979;26:257-309.

2. The architecture of active zone material at the frog's neuromuscular junction

3. The synaptic vesicle cycle: a cascade of protein–protein interactions

4. Ca2+-induced changes in SNAREs and synaptotagmin I correlate with triggered exocytosis from chromaffin cells: insights gleaned into the signal transduction using trypsin and botulinum toxins

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine;Toxins;2024-07-07

2. BOTOX’s Mechanism, Diversity Considerations, and Therapeutic Potential in Cosmetic, Medical, and Dental Practice;European Journal of Medical and Health Research;2024-05-01

3. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment;Handbook of Clinical Neurology;2024

4. Tinnitus and the Somatosensory System;Textbook of Tinnitus;2024

5. Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety;Frontiers in Pharmacology;2023-12-13